Marko Novinec

1.2k total citations
42 papers, 936 citations indexed

About

Marko Novinec is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Marko Novinec has authored 42 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 19 papers in Oncology and 19 papers in Cancer Research. Recurrent topics in Marko Novinec's work include Protease and Inhibitor Mechanisms (19 papers), Peptidase Inhibition and Analysis (16 papers) and Bone Metabolism and Diseases (8 papers). Marko Novinec is often cited by papers focused on Protease and Inhibitor Mechanisms (19 papers), Peptidase Inhibition and Analysis (16 papers) and Bone Metabolism and Diseases (8 papers). Marko Novinec collaborates with scholars based in Slovenia, Switzerland and Austria. Marko Novinec's co-authors include Brigita Lenar≷cic̆, Antonio Baici, Vito Türk, Lidija Kovačič, Marina Klemenčič, Boris Turk, Robert N. Grass, Wendelin J. Stark, Rama Ranganathan and Amedeo Caflisch and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Marko Novinec

40 papers receiving 926 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marko Novinec Slovenia 18 520 279 258 96 82 42 936
Nina Cimerman Slovenia 18 431 0.8× 514 1.8× 233 0.9× 143 1.5× 85 1.0× 21 1.2k
Kristine Mann United States 18 726 1.4× 131 0.5× 521 2.0× 100 1.0× 60 0.7× 32 1.2k
Maurice Pagano France 16 405 0.8× 269 1.0× 179 0.7× 48 0.5× 119 1.5× 41 767
Ding Liu China 18 847 1.6× 241 0.9× 183 0.7× 40 0.4× 80 1.0× 55 1.3k
Hiroko Hatano Japan 16 362 0.7× 127 0.5× 189 0.7× 138 1.4× 53 0.6× 28 869
Jon I. Williams United States 19 645 1.2× 131 0.5× 122 0.5× 31 0.3× 144 1.8× 46 1.1k
Harsh W. Sharma United States 6 688 1.3× 179 0.6× 557 2.2× 40 0.4× 37 0.5× 7 1.4k
Michael Kerr United Kingdom 2 445 0.9× 191 0.7× 194 0.8× 28 0.3× 66 0.8× 4 857
Ravi Sirdeshmukh India 22 985 1.9× 167 0.6× 144 0.6× 24 0.3× 37 0.5× 73 1.6k
P.K. Chiang United States 11 558 1.1× 126 0.5× 165 0.6× 175 1.8× 92 1.1× 25 977

Countries citing papers authored by Marko Novinec

Since Specialization
Citations

This map shows the geographic impact of Marko Novinec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Novinec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Novinec more than expected).

Fields of papers citing papers by Marko Novinec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marko Novinec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Novinec. The network helps show where Marko Novinec may publish in the future.

Co-authorship network of co-authors of Marko Novinec

This figure shows the co-authorship network connecting the top 25 collaborators of Marko Novinec. A scholar is included among the top collaborators of Marko Novinec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marko Novinec. Marko Novinec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Novinec, Marko, et al.. (2023). Regulation of Peptidase Activity beyond the Active Site in Human Health and Disease. International Journal of Molecular Sciences. 24(23). 17120–17120. 12 indexed citations
4.
Massai, Lara, et al.. (2023). Reactions of Medicinal Gold Compounds with Cathepsin B Explored through Electrospray Mass Spectrometry Measurements. ChemPlusChem. 89(2). e202300321–e202300321. 2 indexed citations
5.
Kljun, Jakob, Judith Grau-Expósito, Meritxell Genescà, et al.. (2022). Zinc pyrithione is a potent inhibitor of PL Pro and cathepsin L enzymes with ex vivo inhibition of SARS-CoV-2 entry and replication. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 2158–2168. 23 indexed citations
6.
Strmšek, Žiga, et al.. (2022). Structural polymorphism of coiled-coils from the stalk domain of SARS-CoV-2 spike protein. Repository of the University of Ljubljana (University of Ljubljana). 3 indexed citations
7.
Krahn, Daniel, Kyoko Morimoto, Marko Novinec, et al.. (2022). Activity-based probes trap early active intermediates during metacaspase activation. iScience. 25(11). 105247–105247. 3 indexed citations
8.
Grošelj, Uroš, et al.. (2019). Tetrahydro-1H,5H-pyrazolo[1,2-a]pyrazole-1-carboxylates as inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase. Bioorganic Chemistry. 89. 102982–102982. 17 indexed citations
9.
Klemenčič, Marina, et al.. (2019). Interplay between tetrameric structure, enzymatic activity and allosteric regulation of human dipeptidyl-peptidase I. Archives of Biochemistry and Biophysics. 675. 108121–108121. 6 indexed citations
10.
Petrov, Dražen, Bettina Mayer, Daniel Maresch, et al.. (2018). The two cathepsin B-like proteases of Arabidopsis thaliana are closely related enzymes with discrete endopeptidase and carboxydipeptidase activities. Biological Chemistry. 399(10). 1223–1235. 15 indexed citations
11.
Novinec, Marko. (2017). Computational investigation of conformational variability and allostery in cathepsin K and other related peptidases. PLoS ONE. 12(8). e0182387–e0182387. 15 indexed citations
12.
Tholen, Stefan, Martin L. Biniossek, Bettina Mayer, et al.. (2017). The papain-like cysteine proteinases NbCysP6 and NbCysP7 are highly processive enzymes with substrate specificities complementary to Nicotiana benthamiana cathepsin B. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1865(4). 444–452. 22 indexed citations
13.
Tholen, Stefan, Daniel Maresch, Martin L. Biniossek, et al.. (2016). The death enzyme CP14 is a unique papain-like cysteine proteinase with a pronounced S2 subsite selectivity. Archives of Biochemistry and Biophysics. 603. 110–117. 22 indexed citations
14.
Hira, Vashendriya V.V., Urška Verbovšek, Barbara Breznik, et al.. (2016). Cathepsin K cleavage of SDF-1α inhibits its chemotactic activity towards glioblastoma stem-like cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1864(3). 594–603. 40 indexed citations
16.
Novinec, Marko & Brigita Lenar≷cic̆. (2013). Papain-like peptidases: structure, function, and evolution. BioMolecular Concepts. 4(3). 287–308. 78 indexed citations
17.
Klemenčič, Marina, Marko Novinec, Silke Maier, Ursula Hartmann, & Brigita Lenar≷cic̆. (2013). The Heparin-Binding Activity of Secreted Modular Calcium-Binding Protein 1 (SMOC-1) Modulates Its Cell Adhesion Properties. PLoS ONE. 8(2). e56839–e56839. 22 indexed citations
18.
Novinec, Marko, Brigita Lenar≷cic̆, & Antonio Baici. (2012). Clusterin is a specific stabilizer and liberator of extracellular cathepsin K. FEBS Letters. 586(7). 1062–1066. 11 indexed citations
19.
Bregant, Sarah, Laurent Devel, Marko Novinec, et al.. (2012). A Novel Photoaffinity‐Based Probe for Selective Detection of Cathepsin L Active Form. ChemBioChem. 13(17). 2616–2621. 9 indexed citations
20.
Novinec, Marko, Miha Pavšič, & Brigita Lenar≷cic̆. (2011). A simple and efficient protocol for the production of recombinant cathepsin V and other cysteine cathepsins in soluble form in Escherichia coli. Protein Expression and Purification. 82(1). 1–5. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026